Answers are grounded in this paper and cite their sources.
This approach generates novel PARP1 inhibitors using diffusion models and molecular modeling, indicating potential for drug discovery.
Molecule generation is a critical task in drug discovery, with growing interest in using deep learning to design new compounds. In this study, we propose a novel approach to generate potential PARP1 inhibitors by combining diffusion-based generative models with molecular modeling techniques. Starting from the ZINC20 database, we used diffusion models to create new compounds and applied a predictive model to estimate their PARP1 inhibitory activity. Promising candidates were further evaluated using molecular docking and molecular dynamics simulations to assess their binding affinity. Our results demonstrate the potential of this integrated method to discover novel scaffolds for PARP1 inhibition, supporting future efforts in targeted cancer therapy development.
No takes yet. Share an insight, caveat, or question.
Nguyễn et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: